MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2

Cell Death and Disease

Volumn 5, Issue 2, 2014, Pages

  Ruan, Q ^a,b   Wang, P ^b   Wang, T ^b,c   Qi, J ^b   Wei, M ^b   Wang, S ^a   Fan, T ^a   Johnson, D ^b   Wan, X ^a   Shi, W ^c   Sun, H ^b   Chen, Y H ^b  

^a SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c SHANDONG EYE INSTITUTE   (China)

Author keywords

apoptosis; MiR 21; NF B; Tipe2; TNFAIP8

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 21; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 8 LIKE 2; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNE RESPONSE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL LINE; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; NF-KAPPA B; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TIME FACTORS; TRANSFECTION;

EID: 84896757119     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.47     Document Type: Article

References (59)

1. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ et al. Dicer is essential for mouse development. Nat Genet 2003; 35: 215-217.
2. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
3. He L, Hannon GJ. MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531.
4. Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, Rajewsky K. Aberrant T cell differentiation in the absence of Dicer. J Exp Med 2005; 202: 261-269.
5. Sonkoly E, Stahle M, Pivarcsi A. MicroRNAs and immunity: Novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 2008; 18: 131-140.
6. Xiao C, Rajewsky K. MicroRNA control in the immune system: Basic principles. Cell 2009; 136: 26-36.
7. Schotte D, Pieters R, Den Boer ML. MicroRNAs in acute leukemia: From biological players to clinical contributors. Leukemia 2012; 26: 1-12.
8. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136: 215-233.
9. Nelson P, Kiriakidou M, Sharma A, Maniataki E, Mourelatos Z. The microRNA world: Small is mighty. Trends Biochem Sci 2003; 28: 534-540.
10. Belair C, Darfeuille F, Staedel C. Helicobacter pylori and gastric cancer: Possible role of microRNAs in this intimate relationship. Clin Microbiol Infect 2009; 15: 806-812.
11. Cho WC. OncomiRs: The discovery and progress of microRNAs in cancers. Mol Cancer 2007; 6: 60.
12. Gramantieri L, Fornari F, Callegari E, Sabbioni S, Lanza G, Croce CM et al. MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med 2008; 12: 2189-2204.
13. Selcuklu SD, Donoghue MT, Spillane C. miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 2009; 37: 918-925.
14. Wang Y, Lee CG. MicroRNA and cancer-focus on apoptosis. J Cell Mol Med 2009; 13: 12-23.
15. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65: 6029-6033.
16. Frezzetti D, De Menna M, Zoppoli P, Guerra C, Ferraro A, Bello AM et al. Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene 2011; 30: 275-286.
17. Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, van Rooij E et al. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 2010; 18: 282-293.
18. Krichevsky AM, Gabriely G. miR-21: A small multi-faceted RNA. J Cell Mol Med 2009; 13: 39-53.
19. Morrisey EE. The magic and mystery of miR-21. J Clin Invest 2010; 120: 3817-3819.
20. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. miR-21-mediated tumor growth. Oncogene 2007; 26: 2799-2803.
21. Bostjancic E, Glavac D. Importance of microRNAs in skin morphogenesis and diseases. Acta Dermatovenerol Alp Panonica Adriat 2008; 17: 95-102.
22. Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, Bayless TM et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008; 135: 1624-1635.
23. Ma X, Kumar M, Choudhury SN, Becker Buscaglia LE, Barker JR, Kanakamedala K et al. Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis. Proc Natl Acad Sci USA 2011; 108: 10144-10149.
24. Zhou X, Ren Y, Moore L, Mei M, You Y, Xu P et al. Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab Invest 2010; 90: 144-155.
25. Lu TX, Hartner J, Lim EJ, Fabry V, Mingler MK, Cole ET et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-Type hypersensitivity. J Immunol 2011; 187: 3362-3373.
26. Meisgen F, Xu N, Wei T, Janson PC, Obad S, Broom O et al. MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis. Exp Dermatol 2012; 21: 312-314.
27. Vicinus B, Rubie C, Faust SK, Frick VO, Ghadjar P, Wagner M et al. miR-21 functionally interacts with the 3'UTR of chemokine CCL20 and down-regulates CCL20 expression in miR-21 transfected colorectal cancer cells. Cancer Lett 2012; 316: 105-112.
28. van der Fits L, van Kester MS, Qin Y, Out-Luiting JJ, Smit F, Zoutman WH et al. MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sezary syndrome. J Invest Dermatol 2011; 131: 762-768.
29. Holtzman MJ, Green JM, Jayaraman S, Arch RH. Regulation of T cell apoptosis. Apoptosis 2000; 5: 459-471.
30. Lenardo M, Chan KM, Hornung F, McFarland H, Siegel R, Wang J et al. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 1999; 17: 221-253.
31. Schü tze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Krönke M. TNF activates NFkappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 1992; 71: 765-776.
32. Barkett M, Gilmore TD. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 1999; 18: 6910-6924.
33. Zheng Y, Vig M, Lyons J, Van Parijs L, Beg AA. Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function. J Exp Med 2003; 197: 861-874.
34. Zhang G, Hao C, Lou Y, Xi W, Wang X, Wang Y et al. Tissue-specific expression of TIPE2 provides insights into its function. Mol Immunol 2010; 47: 2435-2442.
35. Zhang L, Shi Y, Wang Y, Zhu F, Wang Q, Ma C et al. The unique expression profile of human TIPE2 suggests new functions beyond its role in immune regulation. Mol Immunol 2011; 48: 1209-1215.
36. Li D, Song L, Fan Y, Li X, Li Y, Chen J et al. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Immunol 2009; 133: 422-427.
37. Sun H, Gong S, Carmody RJ, Hilliard A, Li L, Sun J et al. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 2008; 133: 415-426.
38. Gus-Brautbar Y, Johnson D, Zhang L, Sun H, Wang P, Zhang S et al. The antiinflammatory TIPE2 is an inhibitor of the oncogenic Ras. Mol Cell 2012; 45: 610-618.
39. Niu J, Shi Y, Tan G, Yang CH, Fan M, Pfeffer LM et al. DNA damage induces NF-kappaBdependent microRNA-21 up-regulation and promotes breast cancer cell invasion. J Biol Chem 2012; 287: 21783-21795.
40. Ribas J, Lupold SE. The transcriptional regulation of miR-21, its multiple transcripts, and their implication in prostate cancer. Cell Cycle 2010; 9: 923-929.
41. Shin VY, Jin H, Ng EK, Cheng AS, Chong WW, Wong CY et al. NF-kappaB targets miR-16 and miR-21 in gastric cancer: Involvement of prostaglandin E receptors. Carcinogenesis 2011; 32: 240-245.
42. Fujita S, Ito T, Mizutani T, Minoguchi S, Yamamichi N, Sakurai K et al. miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol 2008; 378: 492-504.
43. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 2010; 39: 493-506.
44. Misawa A, Katayama R, Koike S, Tomida A, Watanabe T, Fujita N. AP-1-Dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP cells. Oncol Res 2010; 19: 23-33.
45. Rozovski U, Calin GA, Setoyama T, D'Abundo L, Harris DM, Li P et al. Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells. Mol Cancer 2013; 12: 50.
46. Darido C, Georgy SR, Wilanowski T, Dworkin S, Auden A, Zhao Q et al. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. Cancer Cell 2011; 20: 635-648.
47. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008; 283: 1026-1033.
48. Frey MR, Carraro G, Batra RK, Polk DB, Warburton D. Sprouty keeps bowel kinases regular in colon cancer, while miR-21 targets Sprouty. Cancer Biol Ther 2011; 11: 122-124.
49. Kwak HJ, Kim YJ, Chun KR, Woo YM, Park SJ, Jeong JA et al. Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 2011; 30: 2433-2442.
50. Liu M, Wu H, Liu T, Li Y, Wang F, Wan H et al. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res 2009; 19: 828-837.
51. Qin W, Zhao B, Shi Y, Yao C, Jin L, Jin Y. BMPRII is a direct target of miR-21. Acta Biochim Biophys Sin (Shanghai) 2009; 41: 618-623.
52. Zheng J, Xue H, Wang T, Jiang Y, Liu B, Li J et al. miR-21 downregulates the tumor suppressor P12 CDK2AP1 and stimulates cell proliferation and invasion. J Cell Biochem 2011; 112: 872-880.
53. Liu C, Li B, Cheng Y, Lin J, Hao J, Zhang S et al. MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3. Int J Biol Sci 2011; 7: 347-363.
54. Liu M, Tang Q, Qiu M, Lang N, Li M, Zheng Y et al. miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells. FEBS Lett 2011; 585: 2998-3005.
55. Kida K, Nakajima M, Mohri T, Oda Y, Takagi S, Fukami T et al. PPARalpha is regulated by miR-21 and miR-27b in human liver. Pharm Res 2011; 28: 2467-2476.
56. Forman JJ, Coller HA. The code within the code: MicroRNAs target coding regions. Cell Cycle 2010; 9: 1533-1541.
57. Huang S, Wu S, Ding J, Lin J, Wei L, Gu J et al. MicroRNA-181a modulates gene expression of zinc finger family members by directly targeting their coding regions. Nucleic Acids Res 2010; 38: 7211-7218.
58. Hu H, Li Y, Gu J, Zhu X, Dong D, Yao J et al. Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells. Leuk Lymphoma 2010; 51: 694-701.
59. Li Y, Zhu X, Gu J, Dong D, Yao J, Lin C et al. Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis. Cancer Sci 2010; 101: 948-954.